Home›Stock Screener›Ind Swift Laboratories

Ind Swift Laboratories Share Price Today | Stock Price & Ind Swift Laboratories Share Screener

INDSWFTLAB Pharmaceuticals
Live Share Price NSE
₹385.75
▼ -9.40 (-2.38%)
2026-10-05 00:00:00
Live Share Price BSE
₹383.95
▼ -11.30 (-2.86%)
2026-10-05 00:00:00

As of October 5, 2026, the live Ind Swift Laboratories share price (NSE: INDSWFTLAB) is ₹385.75 on NSE and ₹383.95 on BSE, down 2.38% from the previous close, with shares trading between ₹383.75 and ₹410.00 in today's trading session, and a 52-week range of ₹88.15–₹413.10. Check INDSWFTLAB 52-week high low for the annual price range and momentum. Use the Ind Swift Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Ind Swift Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹199 and net income of ₹25, with EBITDA of ₹41, an operating margin of 17.0% and a profit margin of 12.6%.

Ind Swift Laboratories Market Cap ₹3,543.80 Cr.
INDSWFTLAB P/E Ratio (TTM) 61.39
Ind Swift Laboratories P/B Ratio 2.54
EPS (TTM) ₹5.16
Dividend Yield -
Debt to Equity 0.01
INDSWFTLAB 52 Week High ₹413.10
Ind Swift Laboratories 52 Week Low ₹88.15
Operating Margin 17.00%
Profit Margin 12.56%
INDSWFTLAB Revenue (TTM) ₹199.00
EBITDA ₹41.00
Net Income ₹25.00
Total Assets ₹1,673.00
Total Equity ₹1,384.00

Ind Swift Laboratories Share Price Chart

Track the current stock price of Ind Swift Laboratories with an interactive chart. Analyse INDSWFTLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Ind Swift Laboratories stock quote in one place.

The quote of ₹385.75 sits between the 52-week low of ₹88.15 and the 52-week high of ₹413.10, and the latest session moved -2.38% from the previous close.

Ind Swift Laboratories Company Profile - Fundamental Screener

Screen Ind Swift Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDSWFTLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE915B01019.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE915B01019

Ind Swift Laboratories Balance Sheet Screener

Screen INDSWFTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1,673, up from ₹1,438 in 2025.

Latest statistics put total assets at ₹1,673 and shareholder funds at ₹1,384, with a leverage ratio of 0.01.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 1,673 1,438 1,165 1,824 1,801 1,818 1,870 1,924 2,023 2,138
Current Assets 977 865 661 1,165 1,075 944 863 836 842 832
Fixed Assets 304 273 8 588 630 753 843 914 934 1,042

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 32 45 12 771 866 901 906 980 534 601
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1,384 1,173 931 682 601 603 641 588 553 531
Share Capital 87 69 59 60 60 60 60 48 46 46
Reserves & Surplus 1,297 1,030 872 622 541 544 581 540 507 486

Ind Swift Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Ind Swift Laboratories income statement and profit fundamentals. Analyze INDSWFTLAB quarterly results. Ind Swift Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹199 and net profit was ₹25, equal to earnings per unit of ₹2.84, at an operating margin of 17%.

In that period expenses were ₹158, interest cost ₹1 and tax ₹8. The next period listed, 2026-Mar, shows revenue of ₹172 and net profit of ₹15.

Item 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec

Revenue and Expenses

Revenue 199 172 178 171 167 359 145 25 44 987 295 297 316 315 321
Expenses 158 154 153 151 149 147 136 24 43 437 236 224 250 267 259

Operating Costs and Margins

EBITDA 41 18 26 19 18 211 9 1 1 549 59 73 66 47 62
Operating Profit % 17.00% 9.00% -1.00% 1.00% 2.00% -7.00% -6.00% -99.00% -29.00% 17.00% 18.00% 23.00% 19.00% 12.00% 17.00%
Depreciation 8 8 9 7 7 7 6 0 0 20 14 13 14 9 15
Interest 1 -2 1 2 1 -27 10 0 0 3 21 21 20 22 22

Profit and Earnings

Profit Before Tax 33 12 16 10 10 231 -7 1 1 527 24 39 32 16 24
Tax 8 -3 7 2 2 8 -1 0 0 33 5 7 14 41 -3
Net Profit 25 15 10 8 9 222 -6 0 1 494 19 32 17 -25 28
EPS 2.84 1.81 1.17 1.00 1.28 32.96 -0.82 0.07 0.16 83.55 3.29 5.36 2.92 -4.25 4.65

Ind Swift Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen INDSWFTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹68, and net cash flow was an inflow of ₹5.

Over the same period, investing activities used ₹69 and financing activities provided ₹142.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -68 -29 -163 195 150 135 125 -64 73 96
Investing Activities -69 -113 -104 -13 5 -10 -9 -13 -17 -31

Financing and Net Cash

Financing Activities 142 72 699 -186 -141 -124 -133 100 -62 -69
Net Cash Flow 5 -69 432 -4 14 1 -17 23 -6 -4

Ind Swift Laboratories Shareholding Pattern Screener

See Ind Swift Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Ind Swift Laboratories promoter holding and ownership changes for INDSWFTLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Feb, promoters held 43.06%, foreign institutions 13.80%, domestic institutions 0.16% and the public 32.97%, spread across 40,404 shareholders.

The shareholder count was 40,404 in 2026-Feb, compared with 39,222 in 2026-Mar.

Item 2026-Feb 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Jul 2025-Aug 2025-Sept

Promoter Holding

Promoter Holding 43.06% 42.99% 42.93% 40.94% 40.94% 36.77% 39.50% 39.50%

Institutional Investors

FII Holding 13.80% 13.88% 10.70% 3.07% 4.27% 0.00% 0.00% 14.80%
DII Holding 0.16% 0.00% 0.17% 0.91% 0.91% 0.00% 0.00% 0.68%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 32.97% 32.90% 34.45% 37.61% 41.36% 35.11% 34.75% 34.96%
Other Holding 10.01% 10.22% 11.75% 17.46% 12.51% 28.12% 25.76% 10.06%
Shareholder Count 40,404 39,222 40,881 28,190 28,709 28,539 28,892 43,780

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Ind Swift Laboratories. Ind Swift Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Ind Swift Laboratories.

Ind Swift Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Ind Swift Laboratories stock. Check INDSWFTLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Ind Swift Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Ind Swift Laboratories Market Events Screener - Corporate Actions

Get Ind Swift Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Ind Swift Laboratories stock events that may affect INDSWFTLAB share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 10, 2026 and Extraordinary General Meeting dated August 5, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-30 2026-09-30 Annual General Meeting NA 9.80%
2026-08-10 2026-08-10 Quarterly Result Announcement NA 1.62%
2026-08-05 2026-08-05 Extraordinary General Meeting NA -1.94%
2026-05-28 2026-05-28 Quarterly Result Announcement NA -0.70%
2026-01-31 2026-01-31 Quarterly Result Announcement NA 6.25%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 1.83%
2025-09-29 2025-09-29 Annual General Meeting NA 1.99%
2025-08-14 2025-08-14 Merger - Demerger 100:15 0.00%
2025-08-13 2025-08-13 Quarterly Result Announcement NA -1.61%
2025-08-11 2025-08-11 Quarterly Result Announcement NA -4.59%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 7.93%
2025-02-22 2025-02-22 Extraordinary General Meeting NA -12.05%
2025-02-13 2025-02-13 Quarterly Result Announcement NA -11.38%
2024-11-11 2024-11-11 Quarterly Result Announcement NA -2.34%
2024-09-30 2024-09-30 Annual General Meeting NA -11.61%

Ind Swift Laboratories Competitors Screener - Peer Stocks Comparison

Screen INDSWFTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 440,998 36.70 61,674 12.69% 11,565 40.74
Divis Laboratories 253,522 87.22 11,067 13.95% 2,568 63.87
Torrent Pharmaceuticals 185,201 87.95 13,886 20.34% 2,138 46.50
Zydus Life Science 122,257 26.11 27,658 17.64% 5,026 66.57
Cipla 111,782 33.64 29,045 2.24% 3,870 45.42
Laurus Labs 108,549 99.16 6,868 22.01% 890 64.04
Dr Reddys Laboratories 101,913 31.54 35,059 3.90% 4,158 63.11
Mankind Pharma 100,589 49.45 14,636 14.85% 1,938 55.24
Aurobindo Pharma 97,670 26.54 34,145 5.56% 3,503 54.66
Lupin 94,281 17.22 29,039 26.75% 5,356 35.30

Ind Swift Laboratories Company Announcements - News & Reports Screener

Screen INDSWFTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated and September 30, 2026.

Date Update Actions
Intimation To The Shareholders Of Physical Securities Pursuant To SEBI Master Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 Dated May 07 2024 -
Closure of Trading Window -
2026-09-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-09-29 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-28 Disclosures Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 -
2026-09-17 Announcement under Regulation 30 (LODR)-Allotment -
2026-09-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-05 Notice Of 31St Annual General Meeting Scheduled To Be Held On Sept. 30 2026 -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-04 Outcome Of Preferential Issue Committee Meeting Held On Friday 4Th September 2026 As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-09-02 Board Meeting Outcome for Outcome Of Board Meeting Held On September 02 2026 -
2026-08-27 Clarification On Movement In Volume -
2026-08-27 Clarification sought from Ind-Swift Laboratories Ltd -
2026-08-20 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-08-18 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-17 Audio Recording Of Earning Conference Call Held On 17.08.2026. -
2026-08-17 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-08-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-08-12 Announcement under Regulation 30 (LODR)-Monitoring Agency Report -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹385.75, within a 52-week range of ₹88.15 to ₹413.10. The P/E ratio is 61.39 and the P/B ratio is 2.54, with earnings per unit of ₹5.16. Market capitalisation stands at ₹3,543.80 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.